Cytomegalovirus retinitis after immune reconstitution

AIDS Reader

Volumn 15, Issue 4, 2005, Pages 186-188

  Crum, Nancy F ^a   Blade, Kent A ^b  

^a Division of Infectious Diseases

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Cytomegalovirus; HIV AIDS; Immune reconstitution; Retinitis

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GANCICLOVIR; LOPINAVIR PLUS RITONAVIR; TENOFOVIR; VALGANCICLOVIR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DRUG IMPLANT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION; IMMUNE RESPONSE; LEUKOCYTE COUNT; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; RETINITIS; TREATMENT OUTCOME; VIRUS LOAD; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; DIFFERENTIAL DIAGNOSIS; PATHOLOGY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS RETINITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV INFECTIONS; HUMANS;

EID: 18244408035     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Deayton JR, Wilson P, Sabin CA, et al. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS. 2000;14:1163-1170.
2. Torriani FJ, Freeman WR, Macdonald JC, et al. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. AIDS. 2000;14:173-180.
3. Johnson SC, Benson CA, Johnson DW, Weinberg A. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis. 2001;32:815-819.
4. + T cell response. J Clin Virol. 2003;26:95-100.
5. + T cell counts and recurrent retinitis. J Infect Dis. 2001;183:1285-1289.
6. Jabs DA, Van Natta ML, Thorne JE, et al. Course of retinitis in the era of highly active antiretroviral therapy, 1: retinitis progression. Ophthalmology. 2004;111:2224-2231.
7. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR. 1999; 48(RR10):1-59. Available at: http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/ rr4810al.htm. Accessed March 9, 2005.
8. + T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated patients. J Clin Virol 2004;29:297-307.
9. Sklar PA, Agyemang AF, Monastra R, et al. Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis. AIDS. 2004;18:567-569.